Back to top
Viveve Medical (VIVE)
(Delayed Data from OTC)
$0.00 USD
0.00
49
0.00 (0.00%)
Updated Oct 30, 2024 02:49 PM ET
NA Value NA Growth NA Momentum NA VGM
View All Zacks #1 Ranked Stocks
Income Statements
Fiscal Year end for Viveve Medical, Inc falls in the month of December .
All items in Millions except EPS data.
| 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
|---|---|---|---|---|---|
| Sales | NA | NA | 6 | 5 | 7 |
| Cost Of Goods | NA | NA | 6 | 5 | 6 |
| Gross Profit | NA | NA | 1 | 0 | 1 |
| Selling & Adminstrative & Depr. & Amort Expenses | 0 | 0 | 22 | 19 | 32 |
| Income After Depreciation & Amortization | 0 | 0 | -22 | -19 | -31 |
| Non-Operating Income | NA | NA | 1 | -2 | -7 |
| Interest Expense | NA | NA | 1 | 1 | 4 |
| Pretax Income | NA | NA | -22 | -22 | -42 |
| Income Taxes | NA | NA | 0 | 0 | 0 |
| Minority Interest | NA | NA | 0 | 0 | 1 |
| Investment Gains/Losses | NA | NA | 0 | 0 | 0 |
| Other Income/Charges | NA | NA | 0 | 0 | 0 |
| Income From Cont. Operations | NA | NA | -22 | -22 | -42 |
| Extras & Discontinued Operations | NA | NA | 0 | 0 | 0 |
| Net Income (GAAP) | NA | NA | -22 | -22 | -43 |
| Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
|---|---|---|---|---|---|
| Income Before Depreciation & Amortization | 0 | 0 | -20 | -17 | -30 |
| Depreciation & Amortization (Cash Flow) | NA | NA | 1 | 1 | 1 |
| Income After Depreciation & Amortization | 0 | 0 | -22 | -19 | -31 |
| Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
|---|---|---|---|---|---|
| Average Shares | NA | NA | 10.09 | NA | 0.13 |
| Diluted EPS Before Non-Recurring Items | NA | NA | -2.65 | NA | -338.00 |
| Diluted Net EPS (GAAP) | NA | NA | -2.65 | -16.56 | -343.90 |
Fiscal Year end for Viveve Medical, Inc falls in the month of December .
All items in Millions except EPS data.
| 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
|---|---|---|---|---|---|
| Sales | NA | NA | NA | NA | NA |
| Cost Of Goods | NA | NA | NA | NA | NA |
| Gross Profit | NA | NA | NA | NA | NA |
| SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non-Operating Income | NA | NA | NA | NA | NA |
| Interest Expense | NA | NA | NA | NA | NA |
| Pretax Income | NA | NA | NA | NA | NA |
| Income Taxes | NA | NA | NA | NA | NA |
| Minority Interest | NA | NA | NA | NA | NA |
| Investment Gains/Losses | NA | NA | NA | NA | NA |
| Other Income/Charges | NA | NA | NA | NA | NA |
| Income From Cont. Operations | NA | NA | NA | NA | NA |
| Extras & Discontinued Operations | NA | NA | NA | NA | NA |
| Net Income (GAAP) | NA | NA | NA | NA | NA |
| Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
|---|---|---|---|---|---|
| Average Shares | NA | NA | NA | NA | NA |
| Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
| Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |